During the past decade, The First Affiliated Hospital of Shantou University Medical College conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 6 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 6 clinical trials were completed. i.e. 54.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The First Affiliated Hospital of Shantou University Medical College" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Pfizer" with 3 trials sponsored, "Beijing Tiantan Hospital" with 1 trials sponsored, "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 1 trials sponsored and "Lepu Medical Technology (Beijing) Co., Ltd." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The First Affiliated Hospital of Shantou University Medical College" #1 collaborator was "Allergan" with 1 trials as a collaborator, "Amylin Pharmaceuticals, LLC." with 1 trials as a collaborator, "Beijing Anzhen Hospital" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "The First Affiliated Hospital of Shantou University Medical College" are "Rheumatoid Arthritis" (2 trials), "Aortic Aneurysm" (1 trials), "Aortic Dissection" (1 trials), "Arthritis" (1 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "The First Affiliated Hospital of Shantou University Medical College" in a lesser frequency.

Most popular intervention types in "The First Affiliated Hospital of Shantou University Medical College" are "Drug" (16 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "ATM-AVI" (2 trials), "Insulin Lispro" (2 trials), "LY2963016" (2 trials) and "Lantus®" (2 trials). Other intervention names were less common.

The vast majority of trials in "The First Affiliated Hospital of Shantou University Medical College" are 19 trials for "All" genders.

Currently, there are NaN active trials in "The First Affiliated Hospital of Shantou University Medical College". 3 are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in The First Affiliated Hospital of Shantou University Medical College, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The First Affiliated Hospital of Shantou University Medical College, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".